Recent Policy Developments and Market Trends in China's Healthcare Sector

Top 10 Major Headlines!

Recently, Jiangsu Yuyue Medical Equipment & Supply Co., Ltd. announced that it would acquire a 61.62% stake in Shanghai Zhongyou Pharmaceutical through an all-cash transaction, with the consideration amounting to RMB 862 million. The acquisition has been viewed favorably by external observers, and synergies between the two parties are expected to materialize in the near future.

It is understood that Yuwell Medical’s current product portfolio spans respiratory care, cardiovascular disease management, hospital equipment, and home healthcare. With the addition of medical disinfection products through this acquisition and expansion, Yuwell Medical has effectively established a comprehensive healthcare industry chain covering medical devices and chronic disease management.

According to Xinhua News Agency, eight provinces in China have signed a service agreement for the inter-provincial networked settlement of medical expenses under the New Rural Cooperative Medical Scheme (NRCMS). The agreement stipulates that insured patients from participating provinces who are referred to designated networked healthcare institutions in other participating provinces can enjoy direct settlement and reimbursement services at the hospital discharge window, making cross-regional medical reimbursement more convenient. The signatory provinces include Liaoning, Jilin, Heilongjiang, Hainan, Sichuan, Guizhou, Shaanxi, and Gansu.

Under the agreement, patients are required to pay only their out-of-pocket expenses upon discharge and settlement. The portion reimbursed by the New Rural Cooperative Medical Scheme (NRCMS) fund is settled between the medical institution and the provincial NRCMS settlement center in the place where medical services were received, with final clearing conducted among the provincial NRCMS settlement centers.

On November 21, Yin Weimin, Minister of Human Resources and Social Security, clearly stated at an event that a policy for gradually raising the retirement age would be introduced in due course. It is reported that the policy framework has already been drafted and is currently undergoing approval procedures by relevant authorities. The plan is expected to be released to the public in 2016 and may be implemented sequentially for different population groups. Although the final target retirement age has not yet been announced, both Minister Yin and experts from the Ministry have indicated that 65 is the common retirement age worldwide.

Recently, Wang Ning, Deputy Mayor of Beijing Municipality, stated in his report on the handling of the proposal titled “Implementing the Regulations of Beijing Municipality on Home-based Elderly Care Services and Strengthening the System and Institutional Framework for Home-based Elderly Care” that Beijing has allocated more than RMB 800 million in special funds this year for home-based elderly care services, with a plan to complete citywide screening of disabled older adults by the end of the year. As of October, 142 out of the 208 street- and township-level elderly care centers planned across the municipality were already in operation. The Beijing Municipal People’s Congress has recommended that relevant authorities issue a timetable for home-based medical services. Over the next five years, 1,000 elderly care stations will be established within the city.

On November 22, Ant Financial announced its open-platform strategy, fully opening up its capabilities in finance, credit, security, data, as well as its proprietary credit scoring and anti-fraud technologies to partners in the healthcare industry. Centered on user health management, the company aims to build an integrated ecosystem linking hospitals, medical insurance, and pharmaceuticals (“the Three-Medical Linkage”), thereby reducing burdens on both patients and physicians, supporting service and management innovation in medical institutions, and making healthcare access simpler and more convenient for the general public.

On November 17, the Fengjie County People’s Government, Alibaba Health, Fengjie County People’s Hospital, and Southwest Hospital of Chongqing signed a four-party agreement. Under this collaboration, Alibaba Health is responsible for designing and implementing technical solutions to establish an internet-based tiered diagnosis and treatment platform. This platform connects village doctors with Fengjie County People’s Hospital and Southwest Hospital, aiming to enhance primary healthcare capabilities and optimize the allocation of high-quality medical resources from large hospitals. The initiative seeks to achieve the goal of “minor illnesses treated within the village, major illnesses managed at the county level, and critical cases referred to provincial hospitals” for rural residents.

On the 17th, WeDoctor and PICC Health Insurance Company Limited signed a strategic cooperation agreement in Wuzhen. Under the agreement, both parties will fully integrate their online and offline resource channels over the next three years and engage in deep collaboration in areas including equity cooperation, customer acquisition, joint development of health products and services, establishment of a joint venture for health management, development and cooperation on medical data platforms, commercial insurance claims processing, public welfare activities for health education, and promotion of healthy behaviors, thereby creating a new model for comprehensive health management services.

Recently, a collaborative study by Mayo Clinic and the Israeli voice analytics company Beyond Verbal found that 13 vocal features are correlated with coronary heart disease (CHD), with one specific vocal feature increasing the likelihood of CHD by 19-fold. Reportedly, vocal feature analysis can assist physicians in assessing the probability of CHD in patients presenting with chest pain, making it particularly suitable for telemedicine applications. This marks the first time that vocal features have been linked to a purely physical disease, suggesting that in the future, physicians may utilize voice analysis software as a non-invasive, adjunctive diagnostic tool.

Illumina, a provider of gene chip solutions, has recently launched TruSight® Tumor 170, a next-generation sequencing solution capable of detecting 170 genes. This launch marks a shift in tumor profiling from single-gene tests to multi-gene assays, offering a more comprehensive view of the tumor genome.

Ascensia Diabetes Care, a new business unit established after Panasonic Healthcare Holdings acquired Bayer’s diabetes care division earlier this year, recently received FDA approval for its connected blood glucose monitoring device, Contour Next One. Primarily designed for the general public, the device enables users to track their diet, exercise, and blood glucose trends via a companion app. Users can also share their data with healthcare providers in PDF format and receive health insights based on multiple data streams.

It is understood that this is the second product they have received approval for this year, with the first being Contour Next Link, which was approved in August and designed specifically for connecting to Medtronic’s insulin pumps.